This hypothesis is strengthened by the observed translocation of HMGB2 expression from nucleus to cytoplasm in the tumor cells at the infiltrative border, which has been previously described as part of the response to immunogenic cell death, and as a predictive biomarker for colon cancer [50,51,56]. This evidence concerns the gene HMGB2 and colonic neoplasm.